After much careful consideration, we have had to take the decision to postpone the 7th Pharmaceutical Sciences World Congress (PSWC) that was due to be held in Montreal, Canada, from 22 to 27 May 2020. The safety and the well-being of our congress participants and their communities is our priority. Our congress registrants have been contacted directly by email with further details. We are currently looking at all the options for when we will hold the 7th PSWC. It is unlikely that it will be held before the end of 2020. We will continue to work with our partners to ensure a successful and vibrant international pharmaceutical science conference, and will issue more information as soon we can. At this critical time, the huge contribution of scientists, alongside all our wider profession has come to the forefront in the global fight against all diseases, most notably COVID-19. We thank you for your work, patience, understanding and continued support during this challenging time. We also thank all the practitioners in community pharmacies and hospitals around the world for their work in the hearts of their communities.
20 March 2020
From diseases to clinical candidates. Participants will explore new concepts in our understanding of disease mechanisms, both at the molecular level as well as systems biology levels, and discuss cutting edge approaches to best discover and design appropriate therapeutic modalities, from small molecules to biologics, cell-based therapies or gene-targeted approaches.
Meeting the challenges of optimal formulation design and manufacture. Participants will discuss how to meet the demands of individualized medicine and global health with cutting-edge formulation, bioanalytical technologies and manufacturing strategies.
From predictive experimental models to optimized clinical studies. Participants will discuss how scientific, technological and regulatory developments can increase success rate in clinical trials and help better individualize treatments, with new predictive experimental models and innovative methods for monitoring treatment exposure and response.
Developing context-appropriate solutions. Participants will learn how real-world evidence may contribute to address individual patient needs or important public health issues with the efficient implementation of therapeutic innovations in a context-appropriate manner in communities around the world.